Diagnos Laboratorium Utama PT Tbk (DGNS) — Capital Reinvestment Ratio
Latest as of June 2025:
1.74x
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Capital Reinvestment Ratio of 1.74x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp1.52 Billion) in capital expenditures (Rp2.64 Billion). See DGNS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.74x
Capex / Operating Cash Flow
Operating Cash Flow
Rp1.52 Billion
IDR
Capital Expenditures
Rp2.64 Billion
IDR
Data as of
Jun 2025
Most recent filing
Diagnos Laboratorium Utama PT Tbk Capital Reinvestment Ratio (2018–2024)
This chart tracks Diagnos Laboratorium Utama PT Tbk's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk (2018–2024)
Year-by-year Capital Reinvestment Ratio for Diagnos Laboratorium Utama PT Tbk from 2018 to 2024. For live market cap and broader valuation context, see DGNS company net worth.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.59x | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp13.18 Billion | Rp38.32 Billion | ▲ +152.3% |
| 2021 | 1.15x | Rp58.87 Billion | Rp67.84 Billion | ▲ +415.4% |
| 2020 | 0.22x | Rp26.23 Billion | Rp5.86 Billion | ▼ -10.0% |
| 2019 | 0.25x | Rp11.20 Billion | Rp2.78 Billion | ▼ -45.2% |
| 2018 | 0.45x | Rp8.47 Billion | Rp3.84 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow